Showing results (1831-1840 of 2,854) with videos related to
Sort By:
Pageof 286
The Journal of Knee Surgery|August 16, 2023
Using a Markerless Motion Capture System to Identify Preinjury Differences in Functional AssessmentsPat Laupattarakasem, James L Cook, James P Stannard, et al.Neurosurgery|October 20, 2023
Short-Term Pain Outcomes and Pain Medication Utilization Among Urine Toxicology-Identified Opioid and Marijuana Users After Elective Spine SurgeryManjot Singh, Ankush Bajaj, Anna Shlimak, et al.Sleep Medicine|February 17, 2020
Design of a deep learning model for automatic scoring of periodic and non-periodic leg movements during sleep validated against multiple human expertsLorenzo Carvelli, Alexander N Olesen, Andreas Brink-Kjær, et al.Oral Oncology|December 14, 2019
Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?A Davies, A Waylen, S Leary, et al.Investigational New Drugs|December 15, 2018
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancerAlexandra Leary, Christophe Le Tourneau, Andrea Varga, et al.Surgical Neurology International|May 5, 2021
Outcomes of infratentorial cranial surgery for tumor resection in older patients: An analysis of the National Surgical Quality Improvement ProgramKrissia M Rivera Perla, Nathan J Pertsch, Owen P Leary, et al.Updates in Surgery|May 16, 2020
Preoperative assessment of skeletal muscle mass during magnetic resonance enterography in patients with Crohn's diseaseV Celentano, L Kamil-Mustafa, R Beable, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 30, 2006
Scanning cytometry with a LEAP: laser-enabled analysis and processing of live cells in situPeter Szaniszlo, William A Rose, Nan Wang, et al.Cancer Chemotherapy and Pharmacology|December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapyAlexandra Leary, L Assersohn, D Cunningham, et al.Transplantation Proceedings|January 9, 2026
Changes in Patient Symptoms After Kidney TransplantationCatherine P King, Amelia R Cossart, Nicole M Isbel, et al.Pageof 286